课题基金 / 基金详情

Protein Acetylation Signature of ES Cell Differentiation

Protein Acetylation Signature of ES Cell Differentiation
ES 细胞分化的蛋白质乙酰化特征
批准号:
7031897
负责人:
ALEXEY V TERSKIKH
金额:
$25.79万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-06 至 2008-05-31

项目摘要

项目成果

ALEXEY V TERSKIKH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):胚胎干细胞的治疗应用将取决于我们获得大量多能干细胞及其预分化后代的能力。干细胞自我更新的分子机制的理解已经投入了大量的努力。尽管近年来取得了一些进展,但对胚胎干细胞自我更新和分化的机制仍知之甚少。我们的初步数据和对文献的分析促使我们提出一个假设,该假设表明(i)细胞内氧化还原状态,(ii)Sirtuin蛋白家族成员,(iii)单个调节蛋白的乙酰化状态,和(iv)干/祖细胞的自我更新与分化决定之间的联系。在这里,我们提出的实验,这开始测试我们的一般假设,即我们将建立蛋白乙酰化的差异之间的ES细胞和它们的分化后代,胚状体和个别Sirtuins在蛋白乙酰化在ES细胞中的作用。我们提出,特异性蛋白质靶点的差异乙酰化/去乙酰化是干细胞分化的关键调节因子之一。特别地,我们推测由Sir 2家族成员介导的蛋白质去乙酰化(由细胞内氧化还原状态介导)调节干细胞自我更新与分化决定。在目标1中,我们将建立未分化的小鼠(ES)细胞及其分化的子代胚状体的蛋白质乙酰化谱(乙酰化特征)。我们提出了一种新的质谱方法来比较多能ES细胞及其分化后代胚状体中整个细胞蛋白质组的乙酰化。在目标2中,我们将小鼠Sir 2家族的单个成员的活性与小鼠ES细胞的乙酰化特征联系起来。我们将利用RNA干扰技术,系统地敲除ES细胞中的小鼠Sir 2家族成员(单独和组合),并分析ES细胞乙酰化谱的变化及其分化潜能。调控胚胎干细胞和潜在的体干细胞的细胞内氧化还原状态以操纵其自我更新状态或诱导分化可能具有重要的实际意义,并构成未来的研究方向。当然,小鼠ES细胞的实验将为调节人类ES细胞的自我更新或诱导分化的工作奠定基础。
英文摘要
DESCRIPTION (provided by applicant): Therapeutic applications of embryonic stem cells will depend on our ability to obtain large amounts of pluripotent stem cells and their predifferentiated progeny. Numerous efforts have been channeled into understanding of the molecular mechanism of stem cell self-renewal. Despite recent advancements, the mechanisms.of self-renewal and differentiation of Embryonic Stem (ES) cells are poorly understood. Our preliminary data and analysis of literature prompted us to formulate a hypothesis suggesting a link between the (i) intracellular redox state, (ii) members of Sirtuin protein family, (iii) acetylation status of individual regulatory proteins, and (iv) the self-renewal vs. differentiation decision of stem/progenitor cells. Here we propose the experiments, which begin testing our general hypothesis, namely we will establish the differences in protein acetylation profile between ES cells and their differentiated progeny, embryoid bodies and the role of individual Sirtuins in protein acetylation in ES cells. We propose that differential acetylation / deacetylation of specific protein targets is one of the key modulators of stem cell differentiation. In particular, we speculate that protein deacetylation mediated by the members of Sir2 family (mediated by the intracellular redox state) regulates the stem cell self-renewal vs. differentiation decision. In Aim 1 we will establish the protein acetylation profile (acetylation signature) of undifferentiated mouse (ES) cells and their differentiated progeny embryoid bodies. We propose a novel mass spectroscopy approach to compare the acetylation of the entire cellular proteome in pluripotent ES cells and in their differentiated progeny, embryoid bodies. In Aim 2 we will link the activity of individual members of mouse Sir2 family with the acetylation signature of mouse ES cells. We will use RNA interference technique, to systematically knock-down the members of mouse Sir2 family (individual and in combination) in ES cells and analyze the changes in acetylation profile of ES cells and their differentiation potential. The modulation of the intracellular redox state of embryonic and potentially somatic stem cells in order to manipulate their self-renewal status or to induce differentiation could be of great practical importance and constitute the future directions of research. Naturally, experiments with mouse ES cells will lay the foundation for the work to modulate self-renewal or induce differentiation of human ES cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Testing the utility of miBioAge as a personalized aging biomarker
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
国内基金
海外基金
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
  • 批准号:
    82371192
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    田婕
  • 依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
  • 批准号:
    82372160
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈峰
  • 依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
  • 批准号:
    82370988
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    经典
  • 依托单位: